Evidence map›Paper›PMID 32645907›Full record

ReviewCells2020

Metabolome Changes in Cerebral Ischemia.

Tae Hwan Shin, Da Yeon Lee, Shaherin Basith, Balachandran Manavalan, Man Jeong Paik, Igor Rybinnik, M Maral Mouradian, Jung Hwan Ahn, Gwang Lee

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 95 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed, 4 pooled it
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

95 citing papers in PubMed, 4 syntheses or guidelines pooled it, 159 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Tae Hwan ShinDepartment of Physiology, Ajou University School of Medicine, Suwon 16499, Korea.ORCID 0000-0001-9686-4556
Da Yeon LeeDepartment of Physiology, Ajou University School of Medicine, Suwon 16499, Korea.
Shaherin BasithDepartment of Physiology, Ajou University School of Medicine, Suwon 16499, Korea.
Balachandran ManavalanDepartment of Physiology, Ajou University School of Medicine, Suwon 16499, Korea.ORCID 0000-0003-0697-9419
Man Jeong PaikCollege of Pharmacy, Sunchon National University, Suncheon 57922, Korea.ORCID 0000-0003-1654-3133
Igor RybinnikDepartment of Neurology, Rutgers - Robert Wood Johnson Medical School, New Brunswick, NJ 08854, USA.
M Maral MouradianDepartment of Neurology, Rutgers - Robert Wood Johnson Medical School, New Brunswick, NJ 08854, USA.
Jung Hwan AhnDepartment of Emergency Medicine, Ajou University School of Medicine, Suwon 16499, Korea.ORCID 0000-0002-4676-1716
Gwang LeeDepartment of Physiology, Ajou University School of Medicine, Suwon 16499, Korea.
Ajou University · KRRutgers, The State University of New Jersey · USSunchon National University · KR

Funding

PP2A Dysregulation in the Pathogenesis of alpha-SynucleinopathiesR01NS101134 · NINDS · RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL · PI MOURADIAN, M. MARAL, NICHOLLS, RUSSELL E · 2017 to 2021
$2.3M
Synergistic Neuroprotective Mechanisms of Coffee Components in Parkinson's DiseasR01AT006868 · NCCIH · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI MOURADIAN, M. MARAL, STOCK, JEFFRY B · 2012 to 2016
$2.2M
NCCIH NIH HHS R01 AT006868NINDS NIH HHS R01 NS101134
6 · The paper itself

Abstract

Cerebral ischemia is caused by perturbations in blood flow to the brain that trigger sequential and complex metabolic and cellular pathologies. This leads to brain tissue damage, including neuronal cell death and cerebral infarction, manifesting clinically as ischemic stroke, which is the cause of considerable morbidity and mortality worldwide. To analyze the underlying biological mechanisms and identify potential biomarkers of ischemic stroke, various in vitro and in vivo experimental models have been established investigating different molecular aspects, such as genes, microRNAs, and proteins. Yet, the metabolic and cellular pathologies of ischemic brain injury remain not fully elucidated, and the relationships among various pathological mechanisms are difficult to establish due to the heterogeneity and complexity of the disease. Metabolome-based techniques can provide clues about the cellular pathologic status of a condition as metabolic disturbances can represent an endpoint in biological phenomena. A number of investigations have analyzed metabolic changes in samples from cerebral ischemia patients and from various in vivo and in vitro models. We previously analyzed levels of amino acids and organic acids, as well as polyamine distribution in an in vivo rat model, and identified relationships between metabolic changes and cellular functions through bioinformatics tools. This review focuses on the metabolic and cellular changes in cerebral ischemia that offer a deeper understanding of the pathology underlying ischemic strokes and contribute to the development of new diagnostic and therapeutic approaches.

Indexed as

AnimalsBrain IschemiaHumansInfarction, Middle Cerebral ArteryMetabolomeMetabolomicscerebral ischemiametabolic networkmetabolomicsmiddle cerebral artery occlusionoxygen-glucose deprivation

Identifiers

PMID32645907
PMCPMC7407387
OpenAlexW3038635856

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.